Dallas Va Research Corporation is located in Dallas, TX. The organization was established in 1991. According to its NTEE Classification (H05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Medical Research and related organizations. As of 09/2021, Dallas VA Research Corporation employed 43 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Dallas VA Research Corporation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2021, Dallas VA Research Corporation generated $2.3m in total revenue. This represents a relatively dramatic decline in revenue. Over the past 6 years, the organization has seen revenues fall by an average of (5.9%) each year. All expenses for the organization totaled $2.5m during the year ending 09/2021. As we would expect to see with falling revenues, expenses have declined by (3.8%) per year over the past 6 years. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
THE MISSION OF THE DALLAS VA RESEARCH CORPORATION IS TO SUPPORT SCIENTIFIC RESEARCH, EDUCATION, AND REHABILITATION TO IMPROVE THE LIVES OF VETERANS AND THEIR FAMILIES.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CLINICAL RESEARCH GRANT/CONTRACT FUNDS ARE DISBURSED TO SUPPORT SPECIFIC RESEARCH PROJECTS PERFORMED UNDER THE SUPERVISION OF, OR BY, TRAINED CLINICIANS AND HEALTHCARE PROVIDERS TO FURTHER VA-APPROVED RESEARCH AND EDUCATIONAL ACTIVITIES. WE HAVE 83 ACTIVE PROJECTS, INCLUDING 73 CLINICAL TRIALS, 1 DEVICE TRIAL, SEVERAL INVESTIGATOR-INITIATED TRIALS AND 4 DATA COLLECTION REGISTRIES. WE HAVE RAMPED UP OUR NEW PROJECT STARTS SIGNIFICANTLY OVER THE PREVIOUS YEAR. THE ORGANIZATION ALSO SHIFTED ITS FOCUS TOWARD STRONGER BUSINESS DEVELOPMENT TO SUPPORT THE REBUILDING OF OUR RESEARCH PORTFOLIO AND TO ATTRACT NEW INVESTIGATORS TO EXTERNALLY-FUNDED RESEARCH.
CONDUCT EDUCATIONAL AND TRAINING EVENTS, WEBINARS AND SEMINARS THAT SUPPORT VA APPROVED RESEARCH.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Michele Packard-Milam Cae Executive Di | Officer | 50 | $154,804 |
Jeffery L Hastings MD Secretary | OfficerTrustee | 1 | $0 |
Stephen R Holt MD Vice Preside | OfficerTrustee | 1 | $0 |
Eddie M Jenkins Us Army Capt Ret Treasurer | OfficerTrustee | 1 | $0 |
James P Lepage PHD Board Presid | OfficerTrustee | 1 | $0 |
John G Modrall MD Director | Trustee | 1 | $0 |
Statement of Revenue | |
---|---|
Federated campaigns | $0 |
Membership dues | $0 |
Fundraising events | $0 |
Related organizations | $0 |
Government grants | $0 |
All other contributions, gifts, grants, and similar amounts not included above | $0 |
Noncash contributions included in lines 1a–1f | $0 |
Total Revenue from Contributions, Gifts, Grants & Similar | $0 |
Total Program Service Revenue | $2,313,111 |
Investment income | $25,662 |
Tax Exempt Bond Proceeds | $0 |
Royalties | $0 |
Net Rental Income | $0 |
Net Gain/Loss on Asset Sales | $0 |
Net Income from Fundraising Events | $0 |
Net Income from Gaming Activities | $0 |
Net Income from Sales of Inventory | $0 |
Miscellaneous Revenue | $0 |
Total Revenue | $2,339,367 |
Statement of Expenses | |
---|---|
Grants and other assistance to domestic organizations and domestic governments. | $0 |
Grants and other assistance to domestic individuals. | $0 |
Grants and other assistance to Foreign Orgs/Individuals | $0 |
Benefits paid to or for members | $0 |
Compensation of current officers, directors, key employees. | $154,804 |
Compensation of current officers, directors, key employees. | $32,249 |
Compensation to disqualified persons | $0 |
Other salaries and wages | $1,652,583 |
Pension plan accruals and contributions | $18,515 |
Other employee benefits | $126,623 |
Payroll taxes | $151,066 |
Fees for services: Management | $0 |
Fees for services: Legal | $2,730 |
Fees for services: Accounting | $5,850 |
Fees for services: Lobbying | $0 |
Fees for services: Fundraising | $0 |
Fees for services: Investment Management | $0 |
Fees for services: Other | $117,619 |
Advertising and promotion | $0 |
Office expenses | $0 |
Information technology | $56,632 |
Royalties | $0 |
Occupancy | $0 |
Travel | $4,924 |
Payments of travel or entertainment expenses for any federal, state, or local public officials | $5,811 |
Conferences, conventions, and meetings | $13,492 |
Interest | $0 |
Payments to affiliates | $0 |
Depreciation, depletion, and amortization | $4,882 |
Insurance | $8,808 |
All other expenses | $13,581 |
Total functional expenses | $2,492,150 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $27,659 |
Savings and temporary cash investments | $1,266,100 |
Pledges and grants receivable | $0 |
Accounts receivable, net | $403,429 |
Loans from Officers, Directors, or Controlling Persons | $0 |
Loans from Disqualified Persons | $0 |
Notes and loans receivable | $0 |
Inventories for sale or use | $0 |
Prepaid expenses and deferred charges | $26,399 |
Net Land, buildings, and equipment | $6,715 |
Investments—publicly traded securities | $1,269,856 |
Investments—other securities | $0 |
Investments—program-related | $0 |
Intangible assets | $0 |
Other assets | $0 |
Total assets | $3,000,158 |
Accounts payable and accrued expenses | $148,499 |
Grants payable | $0 |
Deferred revenue | $21,125 |
Tax-exempt bond liabilities | $0 |
Escrow or custodial account liability | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Secured mortgages and notes payable | $0 |
Unsecured mortgages and notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $169,624 |
Net assets without donor restrictions | $2,830,534 |
Net assets with donor restrictions | $0 |
Capital stock or trust principal, or current funds | $0 |
Paid-in or capital surplus, or land, building, or equipment fund | $0 |
Retained earnings, endowment, accumulated income, or other funds | $0 |
Total liabilities and net assets/fund balances | $3,000,158 |
Over the last fiscal year, we have identified 1 grants that Dallas Va Research Corporation has recieved totaling $134,813.
Awarding Organization | Amount |
---|---|
Fred Hutchinson Cancer Research Center Seattle, WA PURPOSE: VACCINE AND INFECTIOUS DISEASE | $134,813 |
Organization Name | Assets | Revenue |
---|---|---|
Metis Foundation San Antonio, TX | $2,545,676 | $9,772,629 |
Dallas Va Research Corporation Dallas, TX | $3,000,158 | $2,339,367 |
Osteosarcoma Institute Dallas, TX | $6,745,771 | $292,501 |
International Safety Center Inc League City, TX | $6,098 | $197,232 |
Carnot Research Foundation Dallas, TX | $3,343 | $141,414 |
Childrens Optimal Health Austin, TX | $0 | -$123,152 |
Lifeplus Foundation Batesville, AR | $96,872 | $65,781 |
Thomas-Mcmahan Cancer Foundation New Orleans, LA | $161,954 | $54,510 |
International Veterinary Point-Of-Care Ultrasound Society Spicewood, TX | $56,671 | $0 |
Foundation Of Collaborative Unique Science Focus San Antonio, TX | $373,989 | $0 |
Center For Health And Economics Houston, TX | $0 | $0 |